These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7520108)

  • 21. Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma.
    Sun HL; Atenafu EG; Tsang R; Kukreti V; Marras TK; Crump M; Kuruvilla J
    Leuk Lymphoma; 2017 Nov; 58(11):2607-2614. PubMed ID: 28504035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte colony-stimulating factor administration: adverse events.
    D'Souza A; Jaiyesimi I; Trainor L; Venuturumili P
    Transfus Med Rev; 2008 Oct; 22(4):280-90. PubMed ID: 18848155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary toxicity associated with bleomycin.
    Jacka MJ; Chan CK
    Med J Aust; 1995 Feb; 162(4):220-1. PubMed ID: 7533259
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of granulocyte colony-stimulating factor (G-CSF) on bleomycin-induced lung injury of varying severity.
    Adachi K; Suzuki M; Sugimoto T; Yorozu K; Takai H; Uetsuka K; Nakayama H; Doi K
    Toxicol Pathol; 2003; 31(6):665-73. PubMed ID: 14585735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nodular bleomycin toxicity.
    Cohen MB; Austin JH; Smith-Vaniz A; Lutzky J; Grimes MM
    Am J Clin Pathol; 1989 Jul; 92(1):101-4. PubMed ID: 2473646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary toxicity and bleomycin.
    Dirix LY; Schrijvers D; Druwè P; Van den Brande J; Verhoeven D; Van Oosterom AT
    Lancet; 1994 Jul; 344(8914):56. PubMed ID: 7516990
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative effectiveness of pulmonary scintigraphy and radiography in detecting toxic side-effects of Bleomycin treatment (author's transl)].
    Sawas-Dimopoulou C; Samara V; Anezyris N
    J Radiol Electrol Med Nucl; 1975 Feb; 56(2):153-9. PubMed ID: 50444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity.
    Jóna Á; Miltényi Z; Ujj Z; Garai I; Szilasi M; Illés Á
    Expert Opin Drug Saf; 2014 Oct; 13(10):1291-7. PubMed ID: 25135756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bleomycin and pulmonary toxicity.
    Van Barneveld PW; Mulder NH; Van der Mark TW; Sleijfer DT
    Neth J Med; 1985; 28(11):516-23. PubMed ID: 2417127
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy.
    Zagonel V; Babare R; Merola MC; Talamini R; Lazzarini R; Tirelli U; Carbone A; Monfardini S
    Ann Oncol; 1994; 5 Suppl 2():127-32. PubMed ID: 7515645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the pathogenesis of bleomycin lung toxicity.
    Pozzi E; Zanon P
    Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):575-8. PubMed ID: 83311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleomycin induced pulmonary toxicity in patients with germ cell tumours.
    Usman M; Faruqui ZS; ud Din N; Zahid KF
    J Ayub Med Coll Abbottabad; 2010; 22(3):35-7. PubMed ID: 22338413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary toxicity studies of bleomycin tested before and after its expiration date.
    Schlein A; Schurig JE; Baca CD; Bradner WT; Crooke ST
    Cancer Treat Rep; 1981; 65(7-8):727-8. PubMed ID: 6166377
    [No Abstract]   [Full Text] [Related]  

  • 34. Pulmonary toxicity of ABVD chemotherapy and G-CSF in Hodgkin's disease: possible synergy.
    Matthews JH
    Lancet; 1993 Oct; 342(8877):988. PubMed ID: 7692199
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of autologous bone marrow-derived cells mobilized by granulocyte colony stimulating factor on bleomycin-induced lung injury in mice.].
    Jiang HS; Li HP; Hu Y; Chu JX; Chen G; Zhang RX; Zheng H
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Dec; 32(12):902-7. PubMed ID: 20193348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bleomycin-related lung damage: CT evidence.
    Bellamy EA; Husband JE; Blaquiere RM; Law MR
    Radiology; 1985 Jul; 156(1):155-8. PubMed ID: 2408293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination chemothereapy with cis-diamminedichloroplatinum (II) and bleomycin in tumors of the head and neck.
    Wittes RE; Brescia F; Young CW; Magill GB; Golbey RB; Krakoff IH
    Oncology; 1975; 32(5-6):202-7. PubMed ID: 59332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late pulmonary toxicity of bleomycin.
    Willenbacher W; Mumm A; Bartsch HH
    J Clin Oncol; 1998 Sep; 16(9):3205. PubMed ID: 9738596
    [No Abstract]   [Full Text] [Related]  

  • 39. [The pulmonary toxicity of bleomycin. New practical considerations (author's transl)].
    Laccourreye H; Haas C; Basset JM; Haguet JF
    Ann Otolaryngol Chir Cervicofac; 1977; 94(10-11):571-82. PubMed ID: 72515
    [No Abstract]   [Full Text] [Related]  

  • 40. Reversible penile calcifications associated with bleomycin (NSC-125066)-induced pulmonary toxicity.
    Ihde DC; Gormley PE; Francis RS; DeVita VT
    Cancer Chemother Rep; 1975; 59(5):1039-41. PubMed ID: 54214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.